Senseonics: On The Cusp Of Rapid Growth was reported on SeekingAlpha.com, 22 July 2021.
After years of developing its technology, Senseonics is delivering hope to countless patients who need better continuous glucose monitoring. Eversense is such a device that is the “first and only” among various metrics like monitoring months rather than days. Due to the Ascensia partnership, Eversense sales are increasing worldwide. The company is currently launching the Eversense 180 CGM in both the US and worldwide. This is a first-generation sensor with advanced chemistry as a long-term (180 days) real-time glucose monitoring system. Interestingly, there are more development and advancement in the pipeline as shown below.
Senseonics’ state-of-the-art Eversense CGM System offers many advantages for being the “first and only.”
Read more: Senseonics: On The Cusp Of Rapid Growth
Some interesting insights from Dr. Heather Walker, author of The Chronic Scholar: Briding Chronic Illness Experience and The Ivory Tower. Quite a title, huh? Well, Heather hold a PhD in Disability Studies from the University of Illinois Chicago (2019). Using that degree, she works on projects with teams across our health system, and teaches an undergraduate-level disability studies course. And oh yes, she just completed a book project. I specialize in diabetes and its representations in culture, society, and politics.
Other than her doctorate, she is so very qualified as a T1D (diagnosed in 2001, and blogger about my life with diabetes at www.unexpectedblues.com in 2012. Unexpected Blues was a way for her to advocate the only way she knew how, by sharing her story.
Her perspectives are always interesting and thought-provoking. I’d love your feedback after you get a moment to read 2 of her recent posts. PLEASE feel free to share and post your thoughts and views in the comments below!
AN OPEN LETTER TO DOMEE SHI: DIABETES REPRESENTATION IN THE NEW PIXAR TRAILER, TURNING RED
WHAT IS A HEALTHY MINDSET FOR A DIABETIC? This one really resonates with me:
One narrative I’ve spent much time on in the diabetes context is the one that sounds like, “You can do anything. Diabetes doesn’t have to stop or limit you.” The intention, I surmise, in these types of statements is to inspire. The intention is to encourage diabetics to believe in themselves and to try the things they want to do. This narrative assumes that limits are about attitude.
But what is the impact of that? I ask because the undercurrent of this narrative is that if a diabetic person isn’t able to do something, it is because they didn’t try hard enough or because they had a defeatist mentality. That is the impact. That is the message so many diabetic kids and adults take away from the narrative that diabetes doesn’t present limitations.
What’s worse, this narrative also directly reinforces the public’s idea that diabetes is not a serious disease. They see us saying “diabetes doesn’t stop me from doing anything” and wonder, “then why are you telling me you need extra time on an exam or to keep juice near your desk at work?” When we downplay how much diabetes impacts our lives, we inadvertently encourage outsiders to dismiss our hard work – to see it as easy. We get accommodated less often, and when we do, it takes a bigger fight.
So, the “limitless” narrative is destructive to our community by sustaining stigmatizing perceptions of diabetes as a simple, easy, and non-serious disease.
When I read this article this week, I bought some Senseonics shares. My investment advisor said oh do not do that. This is a penny stock. I said not for long. We shall see.